X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2139) 2139
Publication (214) 214
Book Review (38) 38
Book Chapter (8) 8
Dissertation (5) 5
Conference Proceeding (4) 4
Magazine Article (3) 3
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
anastrozole (1920) 1920
humans (1468) 1468
female (1361) 1361
oncology (1180) 1180
breast neoplasms - drug therapy (1144) 1144
tamoxifen (1123) 1123
breast cancer (1089) 1089
postmenopausal women (1067) 1067
index medicus (926) 926
letrozole (760) 760
aromatase inhibitors (717) 717
middle aged (627) 627
antineoplastic agents, hormonal - therapeutic use (532) 532
aged (529) 529
endocrine therapy (507) 507
randomized-trial (486) 486
aromatase inhibitors - therapeutic use (483) 483
postmenopause (451) 451
nitriles - therapeutic use (438) 438
triazoles - therapeutic use (437) 437
breast neoplasms - pathology (434) 434
cancer (414) 414
tamoxifen - therapeutic use (394) 394
exemestane (378) 378
treatment outcome (357) 357
aromatase inhibitor (335) 335
adult (325) 325
chemotherapy, adjuvant (318) 318
estrogen (307) 307
care and treatment (298) 298
therapy (276) 276
double-blind (275) 275
women (267) 267
aged, 80 and over (259) 259
chemotherapy (253) 253
first-line therapy (253) 253
medicine & public health (248) 248
fulvestrant (221) 221
trial (216) 216
aromatase inhibitors - adverse effects (213) 213
breast neoplasms - metabolism (211) 211
obstetrics & gynecology (206) 206
nitriles - administration & dosage (204) 204
triazoles - administration & dosage (204) 204
adjuvant treatment (199) 199
analysis (187) 187
research (187) 187
phase-iii (185) 185
megestrol-acetate (180) 180
antineoplastic agents, hormonal - adverse effects (178) 178
pharmacology & pharmacy (177) 177
drug therapy (176) 176
receptors, estrogen - metabolism (175) 175
combination (171) 171
health aspects (171) 171
nitriles - adverse effects (171) 171
antineoplastic agents - therapeutic use (169) 169
triazoles - adverse effects (168) 168
tamoxifen therapy (167) 167
disease-free survival (165) 165
aromatase (164) 164
randomized controlled trials as topic (160) 160
antineoplastic combined chemotherapy protocols - therapeutic use (159) 159
antineoplastic agents, hormonal - administration & dosage (152) 152
tamoxifen - administration & dosage (149) 149
clinical trials as topic (148) 148
endocrinology & metabolism (147) 147
aromatase inhibitors - administration & dosage (146) 146
clinical trials (146) 146
estradiol - analogs & derivatives (144) 144
neoplasms, hormone-dependent - drug therapy (141) 141
hematology, oncology and palliative medicine (140) 140
breast neoplasms - mortality (139) 139
neoplasm staging (136) 136
prognosis (134) 134
androstadienes - therapeutic use (124) 124
menopause (124) 124
animals (121) 121
estrogen-receptor (121) 121
expression (121) 121
risk factors (121) 121
metastasis (118) 118
efficacy (117) 117
neoadjuvant therapy (114) 114
male (113) 113
survival (113) 113
breast neoplasms - surgery (111) 111
carcinoma (111) 111
adjuvant therapy (110) 110
prevention (108) 108
nitriles - pharmacology (105) 105
retrospective studies (105) 105
triazoles - pharmacology (105) 105
advanced breast-cancer (103) 103
enzyme inhibitors - therapeutic use (103) 103
surgery (102) 102
article (101) 101
tamoxifen - adverse effects (98) 98
double-blind method (96) 96
risk (96) 96
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2086) 2086
German (23) 23
French (22) 22
Spanish (12) 12
Japanese (3) 3
Korean (3) 3
Chinese (2) 2
Turkish (2) 2
Czech (1) 1
Hungarian (1) 1
Italian (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Breast Cancer Research and Treatment, ISSN 0167-6806, 6/2018, Volume 169, Issue 3, pp. 537 - 548
Journal Article
Japanese Journal of Cancer and Chemotherapy, ISSN 0385-0684, 06/2018, Volume 45, Issue 6, pp. 965 - 968
Journal Article
The Journal of Urology, ISSN 0022-5347, 01/2018, Volume 199, Issue 1, pp. 18 - 18
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2019, Volume 380, Issue 23, pp. 2282 - 2282
Overall Survival with Fulvestrant plus Anastrozole in Metastatic Breast Cancer (N Engl J Med 2019;380:1226-1234). In the list of authors (page 1226), Dr.... 
Breast cancer | Metastasis | Anastrozole | Survival | Fulvestrant | Metastases
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2019, Volume 380, Issue 13, pp. 1226 - 1234
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 01/2017, Volume 35, Issue 2, pp. 261 - 261
Journal Article
JAMA OPHTHALMOLOGY, ISSN 2168-6165, 05/2019, Volume 137, Issue 5, pp. 581 - 582
This case report describes a 69-year-old woman with a history of hypertension and breast cancer who presented with blurry vision in both eyes. 
OPHTHALMOLOGY | Breast cancer | Retinopathy | Ophthalmology | Anastrozole
Journal Article
Annals of Oncology, ISSN 0923-7534, 12/2018, Volume 29, Issue 12, pp. 2274 - 2278
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2017, Volume 35, Issue 23, pp. 2718 - 2719
Journal Article
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, ISSN 0027-8874, 09/2005, Volume 97, Issue 17, pp. 1262 - 1271
Background. Most recurrences in women with breast cancer receiving 5 years of adjuvant tamoxifen occur after 5 years. The MA.17 trial, which was designed to... 
CLINICAL-PHARMACOLOGY | ONCOLOGY | ESTROGEN | RECURRENCE | MECHANISMS | QUALITY-OF-LIFE | POSTMENOPAUSAL WOMEN | COMBINATION | AROMATASE INHIBITORS | AMERICAN-SOCIETY | ANASTROZOLE
Journal Article
JNCCN Journal of the National Comprehensive Cancer Network, ISSN 1540-1405, 12/2015, Volume 13, Issue 12, pp. 1475 - 1485
These NCCN Guideline Insights highlight the important updates to the systemic therapy recommendations in the 2016 NCCN Guidelines for Breast Cancer. In the... 
OVARIAN SUPPRESSION | 1ST-LINE TREATMENT | PERTUZUMAB PLUS TRASTUZUMAB | ONCOLOGY | PREOPERATIVE THERAPY | DOUBLE-BLIND | LETROZOLE | POSTMENOPAUSAL WOMEN | CHEMOTHERAPY | NEOADJUVANT | ANASTROZOLE
Journal Article
European Journal of Cancer Care, ISSN 0961-5423, 03/2018, Volume 27, Issue 2, pp. e12834 - n/a
Journal Article
Nigerian Journal of Physiological Sciences, ISSN 0794-859X, 2017, Volume 32, Issue 2, pp. 219 - 225
Although anastrozole (Anas) plays a key role in the management of endocrine sensitive post-menopausal (PM) breast cancer (BC), there is much variability in its... 
Postmenopausal | Breast cancer | Anastrozole | Estradiol
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.